All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

High hematocrit on TRT: what actually works and what doesn't

KMART

TikTok creator

72.1K viewsWatch on TikTok→

Quick answer

Testosterone therapy is a known driver of erythrocytosis through erythropoietin stimulation and hepcidin suppression, producing true increases in red blood cell mass distinct from the relative erythrocytosis seen with dehydration. Hematocrit above 54 percent on TRT warrants clinical evaluation and potential dose adjustment, not hydration-based retesting as a primary strategy. Patients with persistently elevated hematocrit should consult their prescribing provider about dose, frequency, or delivery method changes before assuming lab artifact.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @kmartfit actually say?

The claim is straightforward: if you're on TRT and getting high hematocrit readings, you might just be showing up to the lab dehydrated. @kmartfit says "you gotta be drinking 64 ounces of water before you get a blood test done" to get accurate red blood cell, hematocrit, and hemoglobin numbers. He frames this as a fix, or at least a diagnostic step, before assuming your TRT is actually causing the elevation.

To be fair, he's not saying hydration cures polycythemia. He's saying dehydration can produce a false positive, and that you should rule it out first. That's a narrower, more defensible claim. But the way it's packaged, as a solution to high hematocrit rather than a troubleshooting step, matters a lot when 72,000 people are watching.

Does the science back this up?

Partially, yes. Dehydration genuinely can concentrate blood and produce falsely elevated hematocrit readings. This is not controversial. The problem is that the 64-ounce number is pulled from thin air, and the framing buries a more serious issue.

Hematocrit is a percentage measurement of red blood cells relative to total blood volume. When you're dehydrated, plasma volume drops, so the ratio shifts upward even if your actual red blood cell count hasn't changed. This is called relative erythrocytosis, and it's real. A 2019 review by Caglar et al. in the International Journal of Laboratory Hematology confirmed that pre-analytical variables including hydration status meaningfully affect hematocrit results. Labs generally recommend adequate hydration before blood draws for this reason.

However, testosterone therapy also causes true, absolute erythrocytosis by stimulating erythropoietin production and suppressing hepcidin, which increases iron availability for red blood cell synthesis. This is well-documented. Bachman et al. (2014, Journal of Clinical Endocrinology and Metabolism) found testosterone dose-dependently increased hematocrit in healthy men. Drinking water will not fix that.

What did they get wrong (or right)?

He got the mechanism right but the framing wrong, and that gap is clinically meaningful.

Credit where it's due: dehydration as a confounding variable in hematocrit readings is legitimate and underappreciated. Many men do show up to fasted morning labs without adequate hydration, which can inflate numbers. Checking hydration status before assuming TRT is the culprit is reasonable advice.

But calling this a way to "fix" high hematocrit is misleading. If your hematocrit is running 52-54 percent on TRT, you are not dehydrated. You have testosterone-induced erythrocytosis, and no amount of water addresses that. The actual clinical management of persistent high hematocrit on TRT includes dose reduction, changing injection frequency, switching delivery method, or therapeutic phlebotomy. None of that was mentioned.

There's also no clinical basis for the specific 64-ounce figure. Standard pre-draw hydration recommendations vary by lab and context. Presenting a specific number as fact without a source is the kind of thing that sounds authoritative and isn't.

What should you actually know?

High hematocrit on TRT is one of the more clinically significant side effects of testosterone therapy, and it deserves more than a hydration hack.

Testosterone increases red blood cell production through multiple pathways. Hematocrit above 54 percent is generally considered a threshold for clinical concern because of increased blood viscosity and associated cardiovascular risk, including stroke and thromboembolism. A 2023 analysis by Guo et al. in the Journal of the American Heart Association found elevated hematocrit was associated with increased adverse cardiovascular events in men on testosterone therapy.

If your hematocrit is borderline and you're unsure about your hydration status at the time of the draw, yes, repeat the test well-hydrated. That's sensible. But if you're getting consistently elevated readings across multiple draws, that is a conversation for your prescribing clinician, not a TikTok fix. Dose adjustments, injection frequency changes, and in some cases phlebotomy are the actual tools here. Hydration is a pre-analytical control, not a treatment.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 4 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For High hematocrit on TRT: what actually works and what doesn't, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

High hematocrit on TRT: what actually works and what doesn't is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Testosterone therapy is a known driver of erythrocytosis through erythropoietin stimulation and hepcidin suppression, producing true increases in red blood cell mass distinct from the relative erythrocytosis seen with dehydration.

FormBlends verdict

Testosterone therapy is a known driver of erythrocytosis through erythropoietin stimulation and hepcidin suppression, producing true increases in red blood cell mass distinct from the relative erythrocytosis seen with dehydration. Hematocrit above 54 percent on TRT warrants clinical evaluation and potential dose adjustment, not hydration-based retesting as a primary strategy. Patients with persistently elevated hematocrit should consult their prescribing provider about dose, frequency, or delivery method changes before assuming lab artifact.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone therapy is a known driver of erythrocytosis through erythropoietin stimulation and hepcidin suppression, producing true increases in red blood cell mass distinct from the relative erythrocytosis seen with dehydration. Hematocrit above 54 percent on TRT warrants clinical evaluation and potential dose adjustment, not hydration-based retesting as a primary strategy. Patients with persistently elevated hematocrit should consult their prescribing provider about dose, frequency, or delivery method changes before assuming lab artifact.
  • Dehydration does cause relative erythrocytosis by reducing plasma volume, making hematocrit readings falsely high. This is a real pre-analytical variable, not a myth.
  • Testosterone therapy also causes true erythrocytosis by stimulating erythropoietin production and suppressing hepcidin. Bachman et al. (2014, JCEM) showed dose-dependent hematocrit increases in men on testosterone.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Dehydration does cause relative erythrocytosis by reducing plasma volume, making hematocrit readings falsely high. This is a real pre-analytical variable, not a myth.
  • Testosterone therapy also causes true erythrocytosis by stimulating erythropoietin production and suppressing hepcidin. Bachman et al. (2014, JCEM) showed dose-dependent hematocrit increases in men on testosterone.
  • The specific 64-ounce hydration recommendation has no cited clinical source. Labs vary in their pre-draw hydration guidance and no universal standard supports this number.
  • Hematocrit above 54 percent on TRT is a threshold for clinical concern. Guo et al. (2023, Journal of the American Heart Association) linked elevated hematocrit in testosterone users to increased adverse cardiovascular events.
  • If hematocrit is borderline and hydration at the time of the draw is uncertain, repeating the test well-hydrated is reasonable. If it's consistently elevated across multiple draws, that requires clinical management.
  • Clinical options for testosterone-induced erythrocytosis include dose reduction, more frequent smaller injections, switching to a transdermal formulation, or therapeutic phlebotomy. These are prescriber decisions, not self-managed fixes.
  • Framing hydration as a fix for high hematocrit on TRT is misleading at scale. For men with true testosterone-driven polycythemia, acting on this advice instead of seeking clinical guidance carries real cardiovascular risk.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

KMART · TikTok creator

72.1K views on this video

How to fix high Hematocrit on Testosterone Replacement Therapy TRT #Trt #trtgains #trt101 #trtfamily #trttransformation #trtshots #trtshot #trtforlife #trtdays #trtcommunity #trtbeforeandafter #trtlife #trtgainz #trtformen #trtworld #trtnation #lowt #testosterone #testosteronelevels #testosteroneinjection #testosteronecypionate #testosteronegains #testosteronetherapy #testosteroneboosters #testosteroneshots #testosteroneshot #testosteroneshottime #testosteronehealth #testosteroneforme

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.